• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti Events, LLC's Virtual August Micro-Cap Conference

    8/15/23 10:20:00 AM ET
    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ANEB alert in real time by email

    NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

    Sidoti & Company, LLC, Monday, August 14, 2023, Press release picture

    Presentation Schedule

    *All Times EST

    Wednesday, August 16, 2023 (Day 1)

    8:30-9:00

    Ohmyhome Ltd. (OMH)

    Hookipa Pharma Inc. (HOOK)

    *****

    9:15-9:45

    Loop Industries (LOOP)

    Zomedica Inc (ZOM)

    LEE Enterprises, Inc. (LEE)

    10:00-10:30

    Mativ Holdings, Inc. (MATV)

    DLH Holdings (DLHC)

    T2 Biosystems, Inc. (TTOO)

    10:45-11:15

    Near Intelligence (NIR)

    Surmodics Inc. (SRDX)

    L.B. Foster Company (FSTR)

    11:30-12:00

    IDACORP, Inc (IDA)

    Harvard Bioscience (HBIO)

    Citizens, Inc. (CIA)

    12:15-12:45

    Independence Contract Drilling (ICD)

    Personalis (PSNL)

    Silvercrest Asset Management Group Inc. (SAMG)

    1:00-1:30

    Ideal Power (IPWR)

    Anebulo Pharmaceuticals (ANEB)

    GEE Group (JOB)

    1:45-2:15

    Powell Industries, Inc. (POWL)

    MAIA Biotechnology, Inc. (MAIA)

    Rocky Mountain Chocolate (RMCF)

    2:30-3:00

    Innovative Solutions & Support (ISSC)

    Hillstream BioPharma, Inc. (HILS)

    Super League Gaming, Inc (SLGG)

    3:15-3:45

    Unisys Corporation (UIS)

    Markforged (MKFG)

    CaliberCos Inc. (CWD)

    4:00-4:30

    Sonim Technologies (SONM)

    KLX Energy Services Holdings (KLXE)

    Comstock Inc (LODE)

    1x1s Only

    (16th)

    DevvStream Inc. (DSTRF)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Paysign, Inc. (PAYS)

    *****

    *****

    *****

    *All Times EST

    Thursday, August 17, 2023 (Day 2)

    8:30-9:00

    *****

    AGBA Group (AGBA)

    *****

    9:15-9:45

    MtronPTI (MPTI)

    The Real Brokerage Inc (REAX)

    Splash Beverage Group (SBEV)

    10:00-10:30

    CLIQ Digital AG (CLIQ)

    LifeMD (LFMD)

    Mistras Group (MG)

    10:45-11:15

    Innovative Eyewear, Inc. (LUCY)

    CareCloud (CCLD)

    Granite Construction Inc. (GVA)

    11:30-12:00

    Shapeways (SHPW)

    Processa Pharmaceuticals (PCSA)

    Landsea Homes (LSEA)

    12:15-12:45

    *****

    Modular Medical (MODD)

    Sidus Space (SIDU)

    1:00-1:30

    Daktronics (DAKT)

    Kala Pharmaceuticals (KALA)

    Terran Orbital (LLAP)

    1:45-2:15

    SOBR Safe Inc. (SOBR)

    Xcel Brands (XELB)

    SYLA Technologies (SYT)

    2:30-3:00

    Intellicheck (IDN)

    Alpha Teknova, Inc. (TKNO)

    ClearOne, Inc. (CLRO)

    3:15-3:45

    AudioEye Inc (AEYE)

    Quince Therapeutics (QNCX)

    Astra Space (ASTR)

    4:00-4:30

    Iteris, Inc. (ITI)

    *****

    ARC Document Solutions (ARC)

    1x1s Only

    (17th)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Kelly Services, Inc. (KELYA)

    Paysign, Inc. (PAYS)

    Tennant Company (TNC)

    *****

    *****

    About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
    In 2023, Sidoti & Company, LLC (www.sidoti.com) formed a sister company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the nearly 25 years of experience Sidoti had as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 160 equities of which around 40 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 1,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti Events, LLC and Sidoti & Company, LLC



    View source version on accesswire.com:
    https://www.accesswire.com/774189/Sidoti-Events-LLCs-Virtual-August-Micro-Cap-Conference

    Get the next $ANEB alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANEB
    $DLHC
    $HBIO
    $HOOK

    CompanyDatePrice TargetRatingAnalyst
    Unisys Corporation New
    $UIS
    8/4/2025$9.00Hold → Buy
    Maxim Group
    Personalis Inc.
    $PSNL
    5/15/2025$6.00Buy
    Guggenheim
    Harvard Bioscience Inc.
    $HBIO
    4/9/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    IDACORP Inc.
    $IDA
    4/2/2025Hold → Buy
    Jefferies
    Mativ Holdings Inc.
    $MATV
    3/24/2025$15.50 → $10.00Hold → Buy
    Stifel
    Personalis Inc.
    $PSNL
    3/17/2025$8.00Buy
    Canaccord Genuity
    Surmodics Inc.
    $SRDX
    3/7/2025$43.00Hold → Buy
    Lake Street
    IDACORP Inc.
    $IDA
    1/23/2025Neutral → Buy
    Guggenheim
    More analyst ratings

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    SEC Filings

    View All

    Loop Industries Inc. filed SEC Form 8-K: Other Events

    8-K - Loop Industries, Inc. (0001504678) (Filer)

    8/19/25 4:12:02 PM ET
    $LOOP
    Major Chemicals
    Industrials

    Sonim Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - SONIM TECHNOLOGIES INC (0001178697) (Filer)

    8/14/25 4:16:16 PM ET
    $SONM
    Telecommunications Equipment
    Utilities

    SEC Form 10-Q filed by Innovative Solutions and Support Inc.

    10-Q - INNOVATIVE SOLUTIONS & SUPPORT INC (0000836690) (Filer)

    8/14/25 2:40:48 PM ET
    $ISSC
    EDP Services
    Technology

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    78% of Businesses Are Investing in GenAI -- but Just 36% have the Infrastructure to Support It, New Unisys Study Finds

    Despite surging interest in emerging technology, most organizations lack the IT core to support innovation, risking ROI and security BLUE BELL, Pa., Aug. 19, 2025 /PRNewswire/ -- Unisys (NYSE:UIS) has released a new global report examining how organizations are adapting IT strategies to support emerging technologies, such as generative AI (genAI), agentic AI, and quantum computing. Titled "From Complexity to Clarity: Modernizing Cloud and IT for What Comes Next," the study gathered responses from 1,000 C-Suite and IT executives across eight global markets. Overall, report findings expose a widening gap between business ambitions and IT readiness — raising concerns about wasted investments, s

    8/19/25 9:00:00 AM ET
    $UIS
    EDP Services
    Technology

    Sonim Launches XP3plus 5G Ultra-Rugged Flip Phone on AT&T; FirstNet Certified

    Purpose-Built for First Responders, Military, Government and Enterprise Users in Construction, Hospitality, Manufacturing, and many other use cases that require distraction-free phonesSan Diego, California--(Newsfile Corp. - August 19, 2025) - Sonim Technologies (NASDAQ:SONM) today announced the availability of the XP3plus 5G, its newest ultra-rugged flip phone, on AT&T. Certified for use on FirstNet – the only nationwide wireless communication platform built with and for first responders – the XP3plus 5G is designed to serve the critical communications needs of first responders, government agencies, and enterprise field workers.(C)2025. Sonim Technologies, Inc. All rights reserved. Sonim XP

    8/19/25 7:30:00 AM ET
    $SONM
    Telecommunications Equipment
    Utilities

    Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)

    New York, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an update note on MAIA Biotechnology, Inc. (NYSE:MAIA) following quarterly results. The update note includes detailed information on the MAIA Biotechnology's business, recent updates, management commentary, financial results, valuation, and risks. The full update note is available below. MAIA Biotechnology August 2025 Update Note Highlights from the note include:                                               Strengthens Clinical Momentum in Q2 2025 with Strong Phase 2 NSCLC Survival Data, Fast Track Designation, Global T

    8/18/25 8:00:00 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Mink Brook Asset Management Llc bought $26,015 worth of shares (4,730 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    8/14/25 4:07:56 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Large owner Mink Brook Asset Management Llc bought $421,096 worth of shares (76,563 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    8/11/25 4:19:48 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Director Hart Spencer bought $33,100 worth of shares (20,000 units at $1.66), increasing direct ownership by 6% to 360,370 units (SEC Form 4)

    4 - Loop Industries, Inc. (0001504678) (Issuer)

    8/7/25 8:10:14 PM ET
    $LOOP
    Major Chemicals
    Industrials

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Unisys upgraded by Maxim Group with a new price target

    Maxim Group upgraded Unisys from Hold to Buy and set a new price target of $9.00

    8/4/25 8:36:19 AM ET
    $UIS
    EDP Services
    Technology

    Guggenheim initiated coverage on Personalis with a new price target

    Guggenheim initiated coverage of Personalis with a rating of Buy and set a new price target of $6.00

    5/15/25 8:13:23 AM ET
    $PSNL
    Medical Specialities
    Health Care

    Harvard Biosci downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Harvard Biosci from Overweight to Sector Weight

    4/9/25 8:35:36 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Green James W returned 347,782 shares to the company and covered exercise/tax liability with 44,740 shares, decreasing direct ownership by 14% to 2,452,566 units (SEC Form 4)

    4 - HARVARD BIOSCIENCE INC (0001123494) (Issuer)

    8/19/25 2:39:23 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Large owner Mink Brook Asset Management Llc bought $26,015 worth of shares (4,730 units at $5.50) (SEC Form 4)

    4 - DLH Holdings Corp. (0000785557) (Issuer)

    8/14/25 4:07:56 PM ET
    $DLHC
    Professional Services
    Consumer Discretionary

    Vice President, Operations Mckertcher Terry B sold $389,440 worth of shares (1,500 units at $259.63), decreasing direct ownership by 18% to 7,000 units (SEC Form 4)

    4 - POWELL INDUSTRIES INC (0000080420) (Issuer)

    8/13/25 4:06:34 PM ET
    $POWL
    Electrical Products
    Energy

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Leadership Updates

    Live Leadership Updates

    View All

    Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

    Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board membersQ2 '25 revenue anticipated to be $20.4 million and Company reiterates previously announced Q2 ‘25 gross margin guidance HOLLISTON, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced a CEO succession plan under which John Duke will assume the role of President & CEO following the planned retirement of Jim Green, effective July 28, 2025. Jim Green will be retiring from his President, CEO & Chairman roles at Harvard Bioscience after more than 8 years as Chairman and 6 years as Pre

    7/17/25 7:00:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    ISS Recommends Sonim Technologies Stockholders to Vote "FOR" Company Nominees on the WHITE Proxy Card

    ISS Underscores Orbic's Months of Unreasonable Demands and Incomplete OffersSan Diego, California--(Newsfile Corp. - July 11, 2025) - Sonim Technologies, Inc. (NASDAQ:SONM), a leading provider of rugged mobile solutions, today announced that Institutional Shareholder Services (ISS) has recommended that Sonim stockholders vote "FOR" four of the Company's nominees on the WHITE proxy card ahead of the Company's upcoming Annual Meeting of Stockholders on July 18, 2025. ISS is the global leader in independent shareholder meeting research and issues voting recommendations on more than 50,000 shareholder meetings annually.In its July 10, 2025, report1, ISS determined that Orbic North America, LLC (

    7/11/25 7:30:00 AM ET
    $SONM
    Telecommunications Equipment
    Utilities

    MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board

    Planning for Phase 2 clinical trial in hepatocellular carcinoma (HCC) underway MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced the appointment of two prominent oncologists to its Scientific Advisory Board (SAB), Claudia Fulgenzi, MD, and David J. Pinato, MD, MRCP (UK), PhD. Both are specialists in hepatocellular carcinoma (HCC), a tumor type to be studied in future clinical trials of MAIA's lead candidate ateganosine (THIO) sequenced with a checkpoint inhibitor. As SAB members they will advise MAIA on designs and protocols for its company sponsored trial (C

    6/24/25 8:15:00 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Financials

    Live finance-specific insights

    View All

    Ideal Power Reports Second Quarter 2025 Financial Results

    AUSTIN, Texas, Aug. 14, 2025 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and innovative provider of the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, reports results for its second quarter ended June 30, 2025. "Our first design win customer is nearing completion of their B-TRAN®-enabled solid-state circuit breaker (SSCB) prototype testing. Following their initial product rollout later this year, we anticipate this OEM will expand its offerings to include a suite of B-TRAN®-enabled SSCBs with a wide range of power ratings, presenting us with a significant revenue growth opportunity. Fur

    8/14/25 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    Innovative Solutions & Support Reports Third Quarter 2025 Results

    Innovative Solutions & Support, Inc. (NASDAQ:ISSC) ("IS&S" or the "Company"), a leading provider of advanced avionic solutions for commercial, business aviation and military markets, today reported fiscal third quarter financial results for the three-month period ended June 30, 2025. THIRD QUARTER 2025 HIGHLIGHTS (all comparisons versus the prior year period unless otherwise noted) Net revenue of $24.1 million, +105.2% Gross profit of $8.6 million; gross margin of 35.6% Net Income of 2.4 million, or $0.14 per diluted share Adjusted EBITDA(1) of $4.4 million, +43.3% Ratio of net debt to trailing twelve-month Adjusted EBITDA of 1.1x as of June 30, 2025 (1) Adjusted

    8/14/25 8:30:00 AM ET
    $ISSC
    EDP Services
    Technology

    Harvard Bioscience Announces Second Quarter 2025 Financial Results

    Reports Q2 2025 Revenues of $20.5M, Gross Margin of 56.4%, and Positive Cash Provided by OperationsThird Quarter 2025 Guidance Reflects Improved Operations and Strong Financial DisciplineNew Credit Amendment Signed, Extending Refinance Deadline to December 5th HOLLISTON, Mass., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company") today announced financial results for the second quarter and six months ended June 30, 2025. "We made solid progress in the second quarter exceeding our revenue guidance. In my short time as CEO, I have already seen first-hand the dedication of our team. The fundamentals of the business remain intact with attractive margins a

    8/11/25 7:00:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by HOOKIPA Pharma Inc.

    SC 13G/A - HOOKIPA Pharma Inc. (0001760542) (Subject)

    11/14/24 6:07:08 PM ET
    $HOOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Surmodics Inc.

    SC 13G/A - SURMODICS INC (0000924717) (Subject)

    11/14/24 3:36:00 PM ET
    $SRDX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by IDACORP Inc.

    SC 13G/A - IDACORP INC (0001057877) (Subject)

    11/14/24 1:28:29 PM ET
    $IDA
    Electric Utilities: Central
    Utilities